WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6801 Infant (under 12 months) mortality rate: 1172
GDP / capita (US$): 1'9271 Child (under 5 years) mortality rate: 1822

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 6'092  5'979  5'865  5'752  5'641  4'140  4'043  3'180 
Births 223  222  222  220  219  187  174  154 
Surviving infants 197  196  195  194  192  160  147  130 
Pop. less than 5 years 935  928  921  915  912  703  700  579 
Pop. less than 15 years 2'532  2'499  2'464  2'425  2'391  1'778  1'805  1'394 
Female 15-49 years 1'501  1'467  1'435  1'404  1'372  991  912  715 

Number of reported case

(Click for retrospective incidence data for Sierra Leone)
Diphtheria
Japanese encephalitis
Measles 15  678  1'865  1'089  31  3'575  830  3'625 
Mumps
Pertussis 23  1'619 
Polio* 11  34  38  11 
Rubella 54 
Rubella (CRS)
Tetanus (neonatal) 23  56  12  36  26 
Tetanus (total) 112  12  36  103  871 
Yellow fever 94  361 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sierra Leone)
Vaccine year result method % card seen                                                
BCG 2012  99  EPI   93  99  97  90  90  99*  39  98  36 
DTP1 2012  98  EPI   93  98  91  80  80  99*  33 
DTP3 2012  92  EPI   93  92  91  76  76  91  24  83  13 
HepB_BD         
HepB3 2012  92  EPI   93  92  91  76  76  91 
Hib3 2012  92  EPI   93  92  91  76  76  91 
JapEnc         
MCV 2012  84  EPI   93  85  88  75  70  93  43  75  36 
MCV2         
PCV1          98  80  85 
PCV3 2012  92  EPI   93  92  80  75 
Pol3 2012  92  EPI   93  92  91  76  76  91  26  83 
Rota1         
Rota_last         
Rubella1         
TT2plus 2012  81  EPI   93  81  60  90  90  94  20  81 
PAB         
VAD1          88  99*  73  20  76 
YFV 2012  84  EPI   93  85  88  75  70  92 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sierra Leone)
BCG 99  98  97  97  96  74 
DTP1 98  98  97  95  94  64 
DTP3 92  91  89  86  84  44 
HepB3 92  91  89  86  84 
HepB_BD
Hib3 92  91  89  86  84 
MCV 83  84  83  81  80  37 
MCV2
PAB 87  87  85  85  97  53  85 
PnC3 92  92  75 
Pol3 92  91  88  84  81  46 
Rota_last
YFV 85  85  83  82  80 

Number of districts in the country 14  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 57
From 80 to 89% 36
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +1, +5 months; No Demonstration project
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes From March 2014
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2017  2012 - 2016  2007 - 2011  2007 - 2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 14  14  14  14  13  13  14 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 14  14  14  14  14  14  14 
Nº districts with DTP3 coverage >=80% number 13  14  13  11  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  100  93  79  86  57  43 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 36  29  21  36  57  14   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  No  No    Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%      

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.